THE GLP-1 COMPARISON DESKRESEARCHED OCTOBER 2026
Tirz vs Sema
Home / Brands / Ro review
Advertising disclosure: CoreAge Rx is our featured commercial partner and appears first. Placement is promotional; it is not a clinical superiority ranking. How we are funded
Branded medications + care

Ro review

Ro combines a recurring care membership with access to branded medications. Its fee and the medication charge are separate, so compare both when weighing semaglutide against tirzepatide.

By Tirz vs Sema Editorial  ·  Updated October 8, 2026  ·  Source-based review

What stands out

  • Wegovy and Zepbound access if prescribed
  • Insurance support for selected products

What to weigh

  • Care fee and medication are separate charges.
  • Provider performance is not established by branded-drug trial results.

The provider is separate from the drug manufacturer

Ro’s weight-loss service advertises clinician assessment, ongoing care and access to products including Wegovy and Zepbound. Ro is the care route; the approved medicine retains its own manufacturer, label and formulation.[source]

This matters when interpreting outcomes. A drug trial can inform discussion of that medicine, but it does not measure Ro’s customer service, prescribing decisions or patient results as a platform.

Understand the ongoing care commitment

Ro currently advertises $39 for the first membership month. The continuing monthly plan is $149, while an annual prepaid arrangement is advertised at an equivalent as low as $74 per month. Medication is charged separately.[source]

Prepayment changes the timing and size of the commitment. Compare the amount due now, not only the smaller monthly equivalent, and ask about cancellation or treatment changes under the selected arrangement.

Identify the selected format and dose

Wegovy now includes different formulations, and Ro lists several GLP-1 options. A generic semaglutide price is not enough to identify whether a quote concerns an injection or a pill. Zepbound also has multiple delivery presentations.

Ask for the exact medication and format before comparing medication cost. Insurance eligibility, cash programs and dose-specific pricing can produce different figures for the same ingredient.[source]

A trial comparison is only one input

The head-to-head trial compared particular weekly injected doses over 72 weeks in adults without diabetes. It does not compare every current Wegovy format or settle the best choice for someone with a different clinical history.[source]

The current prescribing information, clinician assessment and sustained affordability all belong in the decision. A larger mean reduction in one study is not a promise about an individual or a provider.

A relevant route for branded options

Ro is useful to examine when a reader wants an online care relationship and help navigating branded medication access. The tradeoff is a separate ongoing care fee in addition to the medicine.

Our Wegovy injection and Zepbound reviews keep the selected drug distinct from the membership. Neither is scored using invented patient outcomes.

THE RESEARCH

Sources & further reading

Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Each source has its own last-checked date below.

  1. Ro: weight-loss careProvider care model and current medication menu · Checked October 8, 2026
  2. Ro: membership and medication pricingSeparate charges, prepayment periods and dose-specific offers · Checked October 8, 2026
  3. Aronne et al., NEJM 2025: tirzepatide compared with semaglutide for obesityPrimary randomized trial abstract; SURMOUNT-5, 751 adults without diabetes, 72 weeks; funded by Eli Lilly · Checked October 8, 2026

Keep reading

Compare individual medication optionsUnderstand the head-to-head trial